Gene therapy for autosomal dominant disorders of keratin

Alfred S Lewin1, Peter M Glazer, Leonard M Milstone

  • 1Department of Molecular Genetics and Microbiology, University of Florida College of Medicine, Gainesville, Florida 32610-0266, USA. lewin@ufl.edu

Insights

Genetic therapies for keratin diseases aim to suppress toxic protein production or correct genetic defects. Viral vectors offer a promising approach for long-term skin gene therapy, overcoming delivery challenges.

Area of Science:

  • Dermatology
  • Genetics
  • Molecular Biology

Background:

  • Dominant mutations in keratin genes cause severe epidermal diseases.
  • These mutations lead to non-functional keratin filaments, resulting in skin fragility and disease.

Purpose of the Study:

  • To explore genetic therapeutic strategies for keratin diseases.
  • To evaluate the potential of gene correction and RNA reduction for treating these conditions.

Main Methods:

  • Discusses gene correction in epidermal cells.
  • Explores RNA interference (RNAi) and other RNA reduction agents.
  • Highlights the challenge of skin impermeability for nucleotide delivery.
  • Proposes viral vectors for delivering gene expression inhibitors.

Main Results:

  • Gene correction is a viable goal for keratin diseases.
  • RNA reduction strategies are becoming plausible.
  • Skin impermeability poses a significant barrier to topical nucleotide delivery.
  • Viral vector-mediated gene delivery is an attractive alternative.

Conclusions:

  • Viral vectors offer a promising route for long-term genetic treatment of skin diseases caused by keratin mutations.
  • Overcoming skin barrier challenges is crucial for effective topical gene therapy.

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Pedigree Analysis01:35

Pedigree Analysis

Overview
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.